HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken Okamura Selected Research

Potassium Iodide (Pima)

8/2022Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment.
7/2020Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
11/2014Remission after potassium iodide therapy in patients with Graves' hyperthyroidism exhibiting thionamide-associated side effects.
2/2012Masked hyperthyroidism in a haemodialysis patient successfully treated by potassium iodide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken Okamura Research Topics

Disease

7Hyperthyroidism
08/2022 - 12/2006
4Vitiligo
01/2022 - 06/2019
4Chronic Kidney Failure (Chronic Renal Failure)
02/2021 - 06/2010
3Neoplasms (Cancer)
01/2021 - 07/2018
2Inflammation (Inflammations)
06/2022 - 01/2022
2Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
06/2022 - 01/2018
2Hypothyroidism
06/2019 - 05/2017
2Goiter
06/2019 - 06/2010
2Chronic Renal Insufficiency
03/2018 - 05/2017
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2014 - 01/2002
2Thyroiditis
01/2012 - 12/2006
1Diarrhea
06/2022
1Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2022
1Graves Disease (Basedow Disease)
02/2022
1Pain (Aches)
02/2022
1Ophthalmoplegia (External Ophthalmoplegia)
02/2022
1Blepharoptosis (Ptosis, Eyelid)
02/2022
1Diplopia (Double Vision)
02/2022
1Paralysis (Palsy)
02/2022
1Respiratory Insufficiency (Respiratory Failure)
01/2022
1Alopecia Areata
01/2022
1Lichen Planus (Lichen Ruber Planus)
01/2022
1Organizing Pneumonia
01/2022
1Pulmonary Aspergillosis
01/2022
1Aspergillus niger infection
01/2022
1Skin Diseases (Skin Disease)
01/2022
1Oculocutaneous albinism type 2
01/2021
1Bites and Stings (Sting)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Neutropenia
07/2020
1Phaeohyphomycosis
07/2020
1Albinism
11/2019
1Darier Disease (Darier's Disease)
10/2019
1Disease Progression
06/2019
1Adenocarcinoma of Lung
01/2019
1Superior Vena Cava Syndrome (Superior Vena Cava Obstruction)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Erythema
01/2019
1Histiocytosis
01/2019
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
07/2018
1Pathologic Complete Response
07/2018
1Cushing Syndrome
07/2018
1Pheochromocytoma
07/2018
1Oculocutaneous Albinism (Albinism, Yellow Mutant)
01/2018
1Hemorrhage
01/2018

Drug/Important Bio-Agent (IBA)

4Potassium Iodide (Pima)FDA Link
08/2022 - 02/2012
3Melanins (Melanin)IBA
11/2020 - 01/2018
2SteroidsIBA
06/2022 - 08/2002
2Small Interfering RNA (siRNA)IBA
01/2022 - 01/2021
2rhododendrolIBA
11/2020 - 06/2019
2Immunoglobulins (Immunoglobulin)IBA
06/2019 - 12/2006
2GlucocorticoidsIBA
07/2018 - 01/2015
2Adrenocorticotropic Hormone (ACTH)FDA Link
07/2018 - 01/2012
2Hydrocortisone (Cortisol)FDA LinkGeneric
07/2018 - 01/2015
2ThyroglobulinFDA Link
05/2017 - 06/2010
1IodidesIBA
08/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2022
1Pharmaceutical PreparationsIBA
06/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
06/2022
1Peroxidase (Myeloperoxidase)IBA
06/2022
1Oxygen (Dioxygen)IBA
06/2022
1thyrotropin-binding inhibitory immunoglobulinIBA
02/2022
1Methimazole (Thiamazole)FDA LinkGeneric
02/2022
1Calcium OxalateIBA
01/2022
1InterferonsIBA
01/2022
1ChemokinesIBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1AlbuminsIBA
02/2021
1Thyroid HormonesIBA
02/2021
11- nitro- 10- (3- dimethylaminopropyl)acridone hydrochloride (C 492)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1CosmeticsIBA
11/2020
1hydroquinone (Esoterica)FDA Link
11/2020
1Ether (Diethyl Ether)IBA
11/2020
1IodineIBA
07/2020
1Terbinafine (Lamisil)FDA LinkGeneric
07/2020
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
10/2019
1Ointments (Pastes)IBA
10/2019
1Janus Kinase InhibitorsIBA
06/2019
1tofacitinibIBA
06/2019
1pembrolizumabIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Monoclonal AntibodiesIBA
01/2019
1CatecholaminesIBA
07/2018
1MetyraponeFDA Link
07/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2018
1CeroidIBA
01/2018
1Antithyroid Agents (Antithyroid Drugs)IBA
01/2015

Therapy/Procedure

6Therapeutics
06/2022 - 08/2002
3Renal Dialysis (Hemodialysis)
02/2021 - 06/2010
2Radiotherapy
01/2019 - 10/2007
1Critical Care (Surgical Intensive Care)
01/2022
1Hemodilution
02/2021
1Immunotherapy
01/2021
1Drug Therapy (Chemotherapy)
07/2020
1Induced Hyperthermia (Thermotherapy)
07/2020
1Adrenalectomy
07/2018
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
03/2018
1Artificial Respiration (Mechanical Ventilation)
01/2015